UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities

Frontiers in microbiology, 2018-05, Vol.9, p.1037-1037

2018

Link zum Volltext

Verfügbarkeit prüfen

Airway microbiota across age and disease spectrum in cystic fibrosis

The European respiratory journal, 2017-11, Vol.50 (5), p.1700832-1700832

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

PloS one, 2013-04, Vol.8 (4), p.e62917-e62917

2013

Link zum Volltext

Verfügbarkeit prüfen

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

Proceedings of the National Academy of Sciences - PNAS, 2007-12, Vol.104 (51), p.20529-20533

2007

Link zum Volltext

Verfügbarkeit prüfen

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis

PloS one, 2016-12, Vol.11 (12), p.e0167649-e0167649

2016

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis

Scientific reports, 2023-01, Vol.13 (1), p.1217-12, Article 1217

2023

Link zum Volltext

Verfügbarkeit prüfen

Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection

BMC microbiology, 2023-10, Vol.23 (1), p.312-312, Article 312

2023

Link zum Volltext

Verfügbarkeit prüfen

Infection, Allergy, and Inflammation: The Role of Aspergillus fumigatus in Cystic Fibrosis

Microorganisms (Basel), 2023-08, Vol.11 (8), p.2013

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis

PloS one, 2016-01, Vol.11 (1), p.e0147643-e0147643

2016

Link zum Volltext

Verfügbarkeit prüfen

Headspace Solid-Phase Micro-Extraction Method Optimization and Evaluation for the Volatile Compound Extraction of Bronchoalveolar Lung Lavage Fluid Samples

Separations, 2024-01, Vol.11 (1), p.27

2024

Link zum Volltext

Verfügbarkeit prüfen

Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens

PloS one, 2010-11, Vol.5 (11), p.e15101

2010

Link zum Volltext

Verfügbarkeit prüfen

Fungal Infection and Inflammation in Cystic Fibrosis

Pathogens (Basel), 2021-05, Vol.10 (5), p.618

2021

Link zum Volltext

Verfügbarkeit prüfen

Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients

PloS one, 2015-04, Vol.10 (4), p.e0125326-e0125326

2015

Link zum Volltext

Verfügbarkeit prüfen

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis

Frontiers in medicine, 2023-01, Vol.9, p.1082125-1082125

2023

Link zum Volltext

Verfügbarkeit prüfen

Sputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis

American journal of respiratory and critical care medicine, 2012-11, Vol.186 (9), p.857-865

2012

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis

BMC pulmonary medicine, 2017-12, Vol.17 (1), p.188-188, Article 188

2017

Link zum Volltext

Verfügbarkeit prüfen

Unraveling the CFTR Function-Phenotype Connection for Precision Treatment in Cystic Fibrosis

American journal of respiratory and critical care medicine, 2019-05, Vol.199 (9), p.1053-1054

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

American journal of respiratory and critical care medicine, 2021-06, Vol.203 (12), p.1522-1532

2021

Link zum Volltext

Verfügbarkeit prüfen

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation

Heliyon, 2020-06, Vol.6 (6), p.e04104-e04104, Article e04104

2020

Link zum Volltext

Verfügbarkeit prüfen

Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis

Health science reports, 2021-03, Vol.4 (1), p.e246-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation

Annals of the American Thoracic Society, 2020-02, Vol.17 (2), p.212-220

2020

Link zum Volltext

Verfügbarkeit prüfen

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing

American journal of respiratory and critical care medicine, 2022-12, Vol.206 (11), p.1308-1310

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular complications in cystic fibrosis: A review of the literature

Journal of cystic fibrosis, 2022-01, Vol.21 (1), p.18-25

2022

Link zum Volltext

Verfügbarkeit prüfen

Bacterial Community Variability: Outliers May Be Leading Us Astray

Annals of the American Thoracic Society, 2019-12, Vol.16 (12), p.1499-1501

2019

Link zum Volltext

Verfügbarkeit prüfen

Entering the era of highly effective CFTR modulator therapy

The Lancet (British edition), 2019-11, Vol.394 (10212), p.1886-1888

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(93)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Cystic Fibrosis
(67)
Life Sciences & Biomedicine
(61)
Humans
(52)
Respiratory System
(40)
Pediatrics
(31)
Female
(28)
Male
(28)
Child
(27)
Cystic Fibrosis - Microbiology
(23)
Adolescent
(19)
Inflammation
(17)
Anti-Bacterial Agents - Therapeutic Use
(15)
Antibiotics
(15)
Cystic Fibrosis - Drug Therapy
(15)
General & Internal Medicine
(15)
Lung Diseases
(15)
Microbiology
(15)
Cystic Fibrosis Transmembrane Conductance Regulator - Genetics
(13)
Mutation
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

On the Use of Diversity Measures in Longitudinal Sequencing Studies of Microbial Communities

Airway microbiota across age and disease spectrum in cystic fibrosis

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis

Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection

Infection, Allergy, and Inflammation: The Role of Aspergillus fumigatus in Cystic Fibrosis

Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis

Headspace Solid-Phase Micro-Extraction Method Optimization and Evaluation for the Volatile Compound Extraction of Bronchoalveolar Lung Lavage Fluid Samples

Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens

Fungal Infection and Inflammation in Cystic Fibrosis

Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis

Sputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis

Unraveling the CFTR Function-Phenotype Connection for Precision Treatment in Cystic Fibrosis

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation

Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis

Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing

Cardiovascular complications in cystic fibrosis: A review of the literature

Bacterial Community Variability: Outliers May Be Leading Us Astray

Entering the era of highly effective CFTR modulator therapy

Suchergebnisse filtern